Orthofix Expects COVID Headwinds Through Second Quarter

Orthofix's logo

Orthofix reported 1Q21 orthopedic revenue of USD $105.6 million, +0.7% vs. 1Q20. The company identified three near-term growth drivers in its M-6 artificial cervical disc, minimally invasive FITBONE technology and expanding spinal interbody portfolio.

The M-6 disc generated $30 million in sales in the last 12 months, bringing Orthofix’s...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us